APA (7th ed.) Citation

Li, B., Rao, J., Hu, W., Yang, Y., Zhou, Q., Wu, Y., . . . Li, P. (2025). Adropin as a therapeutic candidate for HFpEF: Evidence of oxidative stress mitigation via Nrf2/HO-1 signaling. Lipids in Health & Disease, 24(1), 1. https://doi.org/10.1186/s12944-025-02703-6

Chicago Style (17th ed.) Citation

Li, Bingda, Jingan Rao, Wansong Hu, Yuxiu Yang, Qing Zhou, Yingxing Wu, Fangpeng Liu, and Ping Li. "Adropin as a Therapeutic Candidate for HFpEF: Evidence of Oxidative Stress Mitigation via Nrf2/HO-1 Signaling." Lipids in Health & Disease 24, no. 1 (2025): 1. https://doi.org/10.1186/s12944-025-02703-6.

MLA (9th ed.) Citation

Li, Bingda, et al. "Adropin as a Therapeutic Candidate for HFpEF: Evidence of Oxidative Stress Mitigation via Nrf2/HO-1 Signaling." Lipids in Health & Disease, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12944-025-02703-6.